|
|
|||
| Names | |||
|---|---|---|---|
|
IUPAC name
2,3,5,6-Tetramethyl-1,4-benzoquinone
|
|||
| Other names
Tetramethyl-p-benzoquinone
|
|||
| Identifiers | |||
|
3D model (JSmol)
|
|||
| ChEBI | |||
| ChemSpider | |||
| DrugBank | |||
| ECHA InfoCard | 100.007.646 | ||
| UNII | |||
|
|||
|
|||
| Properties | |||
| C10H12O2 | |||
| Molar mass | 164.20408 g/mol | ||
| Melting point | 109 to 114 °C (228 to 237 °F; 382 to 387 K) | ||
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|||
|
|
|||
| Infobox references | |||
Duroquinone is an organic compound (C4(CH3)4O2). It is related to 1,4-benzoquinone by replacement of four H centres with methyl (Me) groups. The C10O2 core of this molecule is planar with two pairs of C=O and C=C bonds.
The compound is produced via nitration of durene (1,2,4,5-tetramethylbenzene) followed reduction to the diamine and then oxidation.
A derived organoiron compound (η2,η2-C4(CH3)4O2)Fe(CO)3 is obtained by the carbonylation of 2-butyne in the presence of iron pentacarbonyl.
The molecule has been mentioned in the popular press as a component of a "nano brain".